Health Canada issues Notice of Compliance for Redemplo (plozasiran) for familial chylomicronemia syndrome

Arrowhead Pharmaceuticals/Plozasiran (Redemplo)

Canada's regulatory authority approved Redemplo for FCS, adding another major market to plozasiran's commercial footprint and demonstrating regulatory validation across three regions.